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Methods
Between July 1983 and August 1985, a total of
400 patients underwent coronary angioplasty on
488 vessels at the Cardiology Centre. There were
358 men (89%) and 42 women (11 %) with a mean
age (±SD) of 55 ±9 years. There were 83 multi-
vessel angioplasties, 56 angioplasties for chronic
total occlusion, and 27 angioplasties for evolving
myocardial infarction. Clinical follow-up was avail-
able in 318 of 400 patients (80%). Of these, 230
patients also underwent control angiography.
The technique of angioplasty which was used has
been described previously*'1. The degree of stenosis
was estimated and averaged by two experienced
angiographers in at least two projections. Primary
success was considered to be present if the following
conditions were fulfilled: angiographically im-
proved stenosis, improvement of transstenotic
pressure gradient, absence of electrocardiographic
or enzymatic evidence of myocardial infarction or
need for bypass surgery, and improvement of
NYHA functional class and/or stress test. In multi-
vessel coronary angioplasty, angiographic success
was considered to be present if at least the dilatation
of the strategic lesions was successful. Restenosis
was defined as a > 50% narrowing of the site of
angioplasty. All patients received aspirin before
angioplasty, most of them were given intracoronary
nifedipine and/or nitrates immediately before
angioplasty and aspirin 100 mg day" l after the pro-
cedure. The pressure used for balloon inflations
ranged from 4 to 14 bar, and the inflation time from
30 to 90 s. Repeat inflations were performed until
the transstenotic pressure gradient had diminished,
and the angiographic aspect of the lesion appeared
satisfactory.
Clinical follow-up consisted of an interview and/
or exercise stress test. A small number of patients
were followed by a questionnaire. Control angio-
graphy was solicited in all patients. Repeat angio-
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graphy was performed promptly in any patient who
referred for recurrence of angina or deterioration in
functional class.
Results
Primary success was obtained in 348 of 400
patients (87%). Major complications were encoun-
tered in 20 patients (5%): one death, 17 (4%) myo-
cardial infarctions, 11 (3%) emergency operations.
Clinical follow-up was available in 318 of 348
patients (91%) with primary success at 10 ±6
months (Fig. 1). Including repeat angioplasty, 80%
of the patients (253/318) with primary success were
improved by at least one NYHA functional class
and/or had an improved exercise test: 19% (61)
were improved by three classes, 31% (97) by two
classes, and 30% (95) by one class. Among the 65
patients with no improvement, there was one
sudden death at 7 months, one patient had a myo-
cardial infarction at 4 months, 16 patients had
bypass surgery, and 47 patients were treated
medically.
Seventy patients had repeat angioplasty at 6±4
months (range 3-24 months) after the first pro-
cedure. At the time of their second procedure, 61 %
(43) were still clinically improved by at least one
functional class: 3% (2) were improved by three
classes, 17% (12) by two classes, and 41% (29) by
one class. Among the other patients 24% (17) were
again in the same class as before angioplasty and
14% (10) were worse than before angioplasty. The
61% with clinical improvement have to be com-
pared to the 88% with clinical improvement among
the 146 patients without recurrence (P<00l).
Angiographic follow-up in 230 patients with
primary success revealed a recurrence in 84 patients
(37%) at 12 ± 6 months. In the subgroup with multi-
vessel angioplasty, recurrence was found in 21 of
the 45 patients (47%) restudied. Recurrence per
artery was 40% (56/140) for the left anterior
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Figure I Follow-up after successful coronary angioplasty.
descending artery, 33% (24/73) for the right coron-
ary artery, 30% (18/61) for the left circumflex
artery, and 29% (4/14) for diagonal branches. Of
these, 70 patients underwent repeat angioplasty, 65
on one vessel, and five on two vessels (Fig. 1).
Primary success was 90% (63/70). There was one
myocardial infarction, and no emergency surgery.
Figure 2 depicts the interval between the first and
the second angioplasty. A control angiography
was performed in 23 of 63 patients with successful
repeat angioplasty. Recurrence was found in 11
patients, representing 17% of the patients with pri-
mary success of repeat angioplasty or 48% of the
patients with angiographic follow-up. In five of
these patients, a third angioplasty was performed
after 7 ± 3 months. It was successful and without
complications in all patients. Medium-term clinical
follow-up (8 ± 6 months) after the last procedure,
available for all 59 patients with repeat angioplasty
who did not undergo surgical revascularization,
showed improvement of at least one NYHA func-
tional class in 84% (50/59). This percentage is
identical to that of the whole group with initial pri-
mary success without subsequent bypass surgery
where long-term clinical improvement was present
in 84% of patients (253/302) after 10 ±6 months.
Discussion
The accuracy of recurrence rates is subject to the
completeness of follow-up angiography. In our
study, as in most others'21, control angiography was
done in only 2/3 of the population studied, showing
recurrence in 37%. One might speculate that most
of the symptomatic patients were restudied and
therefore the real recurrence rate would be less if the
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Figure 2 Distribution of intervals between first and second coronary
angioplasty in 70 patients.
entire population had been subjected to control
angiography.
In patients with angiographically documented
recurrence, there was still a clinical improvement in
61% as compared to the pre-angioplasty status.
This indicates that recurrences in general cause less
symptoms than the initial lesions. Even though
recurrences may be only partial and may be treated
by repeat angioplasty at a low risk, they are fre-
quent and represent a serious problem. This fact
justifies control angiography as well as any effort
towards a better understanding of their pathophy-
siologic mechanism and new methods to diminish
restenosis.
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